Volver al Panel










Becton, Dickinson and Company (BDX)
Valores intradiarios en tiempo real
Resumen del Mercado
From:
To:
BDX Intraday
No data available
SímboloBDX
Fecha de SalidaFeb 21, 1973
CEOMr. Thomas E. Polen Jr.
Empleados a Tiempo Completo72k
SectorHealthcare
IndustriaMedical Instruments & Supplies
PaísUnited States
BolsaNYSE
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Rendimiento
| Período | Rentabilidad % | Cambio de Valor |
|---|---|---|
| 1 Día | -0.77% | -1.54 US$ |
| 5 Días | +3.72% | +7.13 US$ |
| 1 Mes | +8.96% | +16.36 US$ |
| 6 Meses | +30.72% | +46.74 US$ |
Analizando el Mercado con IA
Evaluando los últimos 30 días de historial y métricas fundamentales de BDX...
Estadísticas Clave
Cap. de Mercado
54.18B
Relación P/E
46.26
Rend. de Div.
2.11%
Máx. 52 Semanas
$200.47
Mín. 52 Semanas
$127.59
Consenso de Analistas
CONSENSOCompra
ALCISTA850.0%
NEUTRAL743.8%
BAJISTA16.3%
Objetivos de Precios de Analistas a 52 Semanas
Objetivo Mín.
$165.00
$165.00
Objetivo Máx.
$225.00
$225.00
Actual$198.88
Objetivo Prom.$195.57
Recomendaciones de Analistas
Precio Objetivo:$195.57($165.00 - $225.00)
Pensamientos de la Comunidad
Comparta su análisis y sentimiento sobre BDX
Únase a la comunidad para compartir su análisis
Últimas Noticias para BDX

What Becton Dickinson Stock's New U.S. Manufacturing Deal Means For Shareholders
Simply Wall St.•23 oct 2026, 16:07

Becton Dickinson (BDX) Stock Trades Below Fair Value After A 40% Run
Simply Wall St.•23 oct 2026, 15:18

ResMed Set to Report Q1 Earnings: What's in the Cards for the Stock?
Zacks•23 oct 2026, 11:55

Is Becton Dickinson (BDX) Fully Priced As Execution Improves Before Earnings?
Simply Wall St.•23 oct 2026, 06:08

BDX Stock Gains 25.5% in Six Months: What's Behind the Rally?
Zacks•22 oct 2026, 17:21

Can Boston Scientific Stock Jump 30%?
Trefis•22 oct 2026, 11:45

ILMN Q3 Earnings Preview: Strong Clinical Demand May Lift Performance
Zacks•22 oct 2026, 11:45

Can Boston Scientific Stock Bounce Off This Support Again?
Trefis•22 oct 2026, 01:29

DHR Q3 Earnings Beat on Biotechnology Strength, Sales in Line
Zacks•21 oct 2026, 13:45

BSX Set to Report Q3 Earnings: Will MedSurg Strength Aid Performance?
Zacks•21 oct 2026, 12:26